97 related articles for article (PubMed ID: 22495401)
1. Fascin and cortactin expression is correlated with a poor prognosis in hepatocellular carcinoma.
Huang X; Ji J; Xue H; Zhang F; Han X; Cai Y; Zhang J; Ji G
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):633-9. PubMed ID: 22495401
[TBL] [Abstract][Full Text] [Related]
2. Fascin expression in progression and prognosis of hepatocellular carcinoma.
Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
4. The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma.
Tsai WC; Lin CK; Lee HS; Gao HW; Nieh S; Chan DC; Jin JS
APMIS; 2013 Mar; 121(3):171-81. PubMed ID: 23030700
[TBL] [Abstract][Full Text] [Related]
5. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas.
Won KY; Kim GY; Lim SJ; Park YK; Kim YW
Pathol Res Pract; 2009; 205(11):742-8. PubMed ID: 19556073
[TBL] [Abstract][Full Text] [Related]
8. Fascin expression predicts survival after potentially curative resection of node-positive colon cancer.
Chan C; Jankova L; Fung CL; Clarke C; Robertson G; Chapuis PH; Bokey L; Lin BP; Dent OF; Clarke S
Am J Surg Pathol; 2010 May; 34(5):656-66. PubMed ID: 20410808
[TBL] [Abstract][Full Text] [Related]
9. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
Hsu KF; Lin CK; Yu CP; Tzao C; Lee SC; Lee YY; Tsai WC; Jin JS
Dis Esophagus; 2009; 22(5):402-8. PubMed ID: 19207554
[TBL] [Abstract][Full Text] [Related]
10. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
[TBL] [Abstract][Full Text] [Related]
11. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
12. Fascin, cortactin and survivin expression of melanocytic neoplasms and association with clinicopathological parameters and anatomic locations in Chinese people.
Gao HW; Yu CP; Lee HS; Nieh S; Chiang CP; Wang WM; Jin JS
Eur J Dermatol; 2010; 20(3):293-301. PubMed ID: 20400386
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma.
Chuma M; Sakamoto M; Yasuda J; Fujii G; Nakanishi K; Tsuchiya A; Ohta T; Asaka M; Hirohashi S
J Hepatol; 2004 Oct; 41(4):629-36. PubMed ID: 15464244
[TBL] [Abstract][Full Text] [Related]
16. Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinicopathological parameters.
Tsai WC; Jin JS; Chang WK; Chan DC; Yeh MK; Cherng SC; Lin LF; Sheu LF; Chao YC
J Histochem Cytochem; 2007 Sep; 55(9):955-62. PubMed ID: 17510372
[TBL] [Abstract][Full Text] [Related]
17. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma.
Zou J; Yang H; Chen F; Zhao H; Lin P; Zhang J; Ye H; Wang L; Liu S
Eur J Cancer Prev; 2010 Jan; 19(1):11-7. PubMed ID: 19741544
[TBL] [Abstract][Full Text] [Related]
19. Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis.
Inagaki Y; Xu HL; Hasegawa K; Aoki T; Beck Y; Sugawara Y; Tang W; Kokudo N
J Dig Dis; 2011 Dec; 12(6):481-8. PubMed ID: 22118699
[TBL] [Abstract][Full Text] [Related]
20. Expression of LGR8 and related biomarkers in hepatocellular carcinoma: correlation with clinicopathological parameters.
Lin CK; Jin JS; Yu CP; Tsai WC
Chin J Physiol; 2011 Jun; 54(3):161-8. PubMed ID: 21789898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]